A Study of Nasal Foralumab in Non-Active Secondary Progressive Multiple Sclerosis Patients

NCT06292923 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

54

Enrollment

INDUSTRY

Sponsor class

Conditions

Secondary Progressive Multiple Sclerosis

Interventions

DRUG: Foralumab
OTHER: Placebo

Sponsor

Tiziana Life Sciences LTD